0 items USD 0.00Search
Your search for "Rheumatoid arthritis" gave back 1371 results.
The global Xeljanz (tofacitnib) Drug market size was valued at US$ 1715.9 million in 2023. With growing demand in downstream market, the Xeljanz (...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
LPI
March 2024
Price: USD 3,660.00
Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
January 2024
Price: USD 2,900.00
An antinuclear antibody tests (ANA) are used to evaluate quantity and pattern of antibodies in the blood. Â鶹Դ´ Analysis and Insights: Global...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
December 2024
Price: USD 4,900.00
Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
January 2024
Price: USD 2,900.00
The global Celecoxib market size is predicted to grow from US$ 1460 million in 2025 to US$ 2410 million in 2031; it is expected to grow at a CAGR of...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
LPI
January 2025
Price: USD 3,660.00
The global Jakinibs market size was valued at USD 15030 million in 2023 and is forecast to a readjusted size of USD 32960 million by 2030 with a CAGR...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
GIR
July 2024
Price: USD 3,480.00
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
March 2024
Price: USD 3,950.00
Dexamethasone palmitate injection is a non-specific steroidal anti-inflammatory drug used for the treatment of chronic rheumatoid arthritis...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
LPI
May 2024
Price: USD 3,660.00
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
GIR
September 2024
Price: USD 3,480.00
The global market for Diflunisal was valued at US$ 373 million in the year 2024 and is projected to reach a revised size of US$ 529 million by 2031,...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
January 2025
Price: USD 2,900.00
The global market for Methotrexate was valued at US$ 545 million in the year 2024 and is projected to reach a revised size of US$ 655 million by 2031...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
January 2025
Price: USD 2,900.00
Treatment of drugs for regulating rheumatic diseases Highlights The global Rheumatic Disorders Drug market was valued at US$ million in 2022 and is...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
May 2023
Price: USD 2,900.00
A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
March 2024
Price: USD 2,900.00
Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
September 2024
Price: USD 3,950.00
Tocilizumab is a monoclonal antibody that targets and inhibits interleukin-6 (IL-6) receptors,which are involved in the inflammatory response.By...
°ä²¹³Ù²¹±ô´Ç²µ:Ìý
MRRPB5
August 2024
Price: USD 2,900.00
Ìý
